Sudarshan Chemical Industries Robust Financial Performance for Fiscal Year 2026

Sudarshan Chemical Industries has announced strong financial results for the fiscal year ended March 31, 2026. The company reported a standalone revenue of ₹2,396.7 crore and a profit of ₹290.3 crore for the year. Furthermore, the Board has recommended a final dividend of ₹5 per share, representing a 250% payout, underscoring the company’s strong operational focus and commitment to delivering value to its shareholders.

Financial Highlights

For the fiscal year ended March 31, 2026, Sudarshan Chemical Industries achieved a standalone revenue from operations of ₹2,396.7 crore, with profit for the year standing at ₹290.3 crore. In the final quarter (Q4), the company demonstrated strong performance, recording revenue of ₹732.7 crore and a quarterly profit of ₹120.4 crore. This reflects the company’s resilient operational efficiency amidst a dynamic market environment.

Dividend Recommendation

Demonstrating its commitment to shareholder returns, the Board of Directors has recommended a final dividend of ₹5 per equity share (a face value of ₹2 per share). This translates to a 250% dividend payout, which will be subject to approval by shareholders at the upcoming Annual General Meeting and processed within 30 days of declaration.

Operational Appointments

The company has fortified its governance and audit functions for the fiscal year 2026-27. PricewaterhouseCoopers Services LLP has been appointed as the Internal Auditor, bringing their extensive expertise in risk consulting. Additionally, Mrs. Ashwini Kedar Joshi has been appointed as the Cost Auditor to ensure rigorous oversight of the company’s cost structures and audit compliance.

Strategic Outlook

Sudarshan Chemical continues to focus on its core ‘Pigments’ business, while the ‘Others’ segment—comprising grinding, clean air, and power handling solutions—remains a strategic pillar. The company’s consolidated operations, which include the integration of the acquired Heubach Group, reported annual revenue of ₹9,787.2 crore, highlighting the expanded scale of the organization following recent global business acquisitions.

Source: BSE

Previous Article

Poly Medicure Limited Strong Growth and Strategic Expansion in Q4 & FY26 Results